These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

394 related items for PubMed ID: 10228796

  • 1. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J, Lauerova L, Janakova L, Talac R, Simickova M, Nekulova M, Mikulikova I, Kovarik J, Sheard M.
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [Abstract] [Full Text] [Related]

  • 2. Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients.
    Lauerová L, Dusek L, Spurny V, Simicková M, Rovny A, Rejthar A, Kocák I, Kovarík J.
    Oncol Rep; 2001; 8(3):685-92. PubMed ID: 11295103
    [Abstract] [Full Text] [Related]

  • 3. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 4. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L, Dusek L, Simícková M, Rovný F, Spurný V, Rovný A, Slampa P, Zaloudík J, Rejthar A, Wotke J, Kovarík J.
    Neoplasma; 1999 Jun; 46(3):141-9. PubMed ID: 10613588
    [Abstract] [Full Text] [Related]

  • 5. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A, Lai P, Santona MC, Pagliara L, Melis GB, Mantovani G.
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [Abstract] [Full Text] [Related]

  • 6. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
    Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y.
    Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
    [Abstract] [Full Text] [Related]

  • 7. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B, Akça D, Jung T, Muller GA, Reuss-Borst MA.
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [Abstract] [Full Text] [Related]

  • 8. The effect of colorectal cancer upon host peripheral immune cell function.
    Evans CF, Galustian C, Bodman-Smith M, Dalgleish AG, Kumar D.
    Colorectal Dis; 2010 Jun; 12(6):561-9. PubMed ID: 19250260
    [Abstract] [Full Text] [Related]

  • 9. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M, Manolova I, Kyurkchiev D, Julianov A, Altunkova I.
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [Abstract] [Full Text] [Related]

  • 10. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
    Martí F, Pardo N, Peiró M, Bertran E, Amill B, García J, Cubells J, Rueda F.
    Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
    [Abstract] [Full Text] [Related]

  • 11. Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections.
    Ordemann J, Jacobi CA, Schwenk W, Stösslein R, Müller JM.
    Surg Endosc; 2001 Jun; 15(6):600-8. PubMed ID: 11591950
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pretreatment with interleukin-2 modulates perioperative immunodysfunction in patients with renal cell carcinoma.
    Böhm M, Ittenson A, Klatte T, Schierbaum KF, Röhl FW, Ansorge S, Allhoff EP.
    Folia Biol (Praha); 2003 Jun; 49(2):63-8. PubMed ID: 12779014
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer.
    Wagner P, Koch M, Nummer D, Palm S, Galindo L, Autenrieth D, Rahbari N, Schmitz-Winnenthal FH, Schirrmacher V, Büchler MW, Beckhove P, Weitz J.
    Ann Surg Oncol; 2008 Aug; 15(8):2310-7. PubMed ID: 18521684
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Decreased cell-mediated immune status in colorectal cancer patients with hepatic metastasis.
    Shimizu H, Ito H, Kimura F, Togawa A, Yoshidome H, Ohtsuka M, Kato A, Nukui Y, Miyazaki M.
    Hepatogastroenterology; 2005 Aug; 52(64):1106-9. PubMed ID: 16001640
    [Abstract] [Full Text] [Related]

  • 19. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S, Shiota G, Kawasaki H.
    Hepatogastroenterology; 2003 Aug; 50(53):1569-74. PubMed ID: 14571788
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.